"10.1371_journal.pone.0078679","plos one","2013-11-11T00:00:00Z","Alphonse Ou√©draogo; Alfred B Tiono; D√©sir√© Kargougou; Jean Baptiste Yaro; Esperance Ou√©draogo; Youssouf Kabor√©; David Kangoye; Edith C Bougouma; Adama Gansane; Noelie Henri; Amidou Diarra; Souleymane Sanon; Issiaka Soulama; Amadou T Konate; Nora L Watson; Valerie Brown; Jenny Hendriks; Maria Grazia Pau; Isabella Versteege; Edison Wiesken; Jerald Sadoff; Issa Nebie; Sodiomon B Sirima","Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso; EMMES Corporation, Rockville, Maryland, United States of America; Crucell Holland BV, Leiden, The Netherlands; Groupe d‚Äôaction et de Recherche en Sant√©, Ouagadougou, Burkina Faso","Conceived and designed the experiments: AO ABT ATK JH MGP IV JS IN SBS. Performed the experiments: AO ABT D. Kargougou JBY EO YK D. Kangoye ECB AG NH AD SS IS ATK VB JH MGP EW IV JS IN SBS. Analyzed the data: AO ABT ATK NLW VB JH MGP EW IV JS IN SBS. Contributed reagents/materials/analysis tools: NH AD SS IS JH MGP EW IV JS IN SBS. Wrote the manuscript: AO ABT D. Kargougou JBY EO YK D. Kangoye ECB AG NH AD SS IS ATK NLW VB JH MGP EW IV JS IN SBS.","NLW & VB are employees of The EMMES Corporation. JH, MGP, IV, EW & JS are employees of Crucell Holland BV. Ad35.CS.01 vaccine product, used in this study, was produced by Crucell Holland BV. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","11","Alphonse Ou√©draogo","AO√",23,TRUE,9,3,12,3,TRUE,TRUE,TRUE,5,"4;5;6;8;9",TRUE
